David A. Siegel Artivion, Inc. Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Artivion, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 56,400 shares of AORT stock, worth $1.45 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,400
Previous 38,100
48.03%
Holding current value
$1.45 Million
Previous $681,000
75.18%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding AORT
# of Institutions
151Shares Held
34.8MCall Options Held
18KPut Options Held
1.5K-
Black Rock Inc. New York, NY6.74MShares$173 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.8MShares$71.8 Million0.07% of portfolio
-
Perceptive Advisors LLC New York, NY2.67MShares$68.5 Million1.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.66MShares$68.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.34MShares$59.9 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.03B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...